BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 10699991)

  • 1. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer.
    Leek RD; Hunt NC; Landers RJ; Lewis CE; Royds JA; Harris AL
    J Pathol; 2000 Mar; 190(4):430-6. PubMed ID: 10699991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.
    Leek RD; Landers R; Fox SB; Ng F; Harris AL; Lewis CE
    Br J Cancer; 1998 Jun; 77(12):2246-51. PubMed ID: 9649140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas.
    Lewis JS; Landers RJ; Underwood JC; Harris AL; Lewis CE
    J Pathol; 2000 Oct; 192(2):150-8. PubMed ID: 11004690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E.
    Scott PA; Smith K; Poulsom R; De Benedetti A; Bicknell R; Harris AL
    Br J Cancer; 1998 Jun; 77(12):2120-8. PubMed ID: 9649123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
    Ueno T; Toi M; Saji H; Muta M; Bando H; Kuroi K; Koike M; Inadera H; Matsushima K
    Clin Cancer Res; 2000 Aug; 6(8):3282-9. PubMed ID: 10955814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma.
    Valković T; Dobrila F; Melato M; Sasso F; Rizzardi C; Jonjić N
    Virchows Arch; 2002 Jun; 440(6):583-8. PubMed ID: 12070596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.
    Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
    J Pathol; 2001 Mar; 193(3):325-32. PubMed ID: 11241411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis.
    Fujimoto K; Hosotani R; Wada M; Lee JU; Koshiba T; Miyamoto Y; Tsuji S; Nakajima S; Doi R; Imamura M
    Eur J Cancer; 1998 Aug; 34(9):1439-47. PubMed ID: 9849429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH; Dublin EA; Bobrow LG; Poulsom R
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor.
    Callagy G; Dimitriadis E; Harmey J; Bouchier-Hayes D; Leader M; Kay E
    Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):104-9. PubMed ID: 10937057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
    Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC
    Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
    Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
    Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Cox J; Krammer B; Gatter KC; Harris AL
    Clin Exp Metastasis; 1999; 17(7):545-54. PubMed ID: 10845553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
    Salvesen HB; Akslen LA
    Int J Cancer; 1999 Oct; 84(5):538-43. PubMed ID: 10502735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Thorpe PE; Brekken RA; Konstantinos S; Fountzilas G; Gatter KC; Harris AL
    Clin Exp Metastasis; 2000; 18(4):313-9. PubMed ID: 11448062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor in invasive ductal carcinoma of the breast and the relation to angiogenesis and p53 and HER-2/neu protein expression.
    Lee JS; Kim HS; Jung JJ; Kim YB; Lee MC; Park CS
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):289-95. PubMed ID: 12607595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: dichotomus effect predictable by the HIFI alpha/VEGF pre-treatment status?
    Koukourakis MI; Simopoulos C; Polychronidis A; Perente S; Botaitis S; Giatromanolaki A; Sivridis E
    Anticancer Res; 2003; 23(2C):1673-80. PubMed ID: 12820439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.